Tuberculosis and multidrug resistance: an integrative review
DOI:
https://doi.org/10.33448/rsd-v11i5.27112Keywords:
Tuberculosis resistant to multiple drugs; Public health; Epidemiology.Abstract
The resistance developed by Mycobacterium tuberculosis to the drugs used in the treatment constitutes a major public health problem in several countries and is considered one of the main obstacles to the control of tuberculosis worldwide. Thus, the objective was to analyze the factors associated with the prevalence of tuberculosis resistant to multiple drugs, through an integrative literature review of the last 5 years, using the LILACS, MEDLINE and SCIELO databases, which make up the Virtual Health Library. The result was 726 articles, of which 49 were pre-selected to be read in full, resulting in 14 approved articles. It was observed that many of the accepted articles had as place of study the Asian continent and South America. Therefore, strategies for controlling MDR-TB should emphasize the effective implementation of the strategy for continuous surveillance of drug resistance and patient-centered approaches.
References
Alves, S. L. A. et al., (2011). Dados clínicos e análise molecular de isolados de Mycobacterium tuberculosis de pacientes com tuberculose resistente a medicamentos em Goiás, Brasil. Mem. Inst. Oswaldo Cruz, 106 (6): Rio de Janeiro, set.
Ballestero, J. G. A. et al., (2014). Tuberculose multirresistente: abrangência da atenção à saúde em uma perspectiva discursiva. Esc. Anna Nery, 18 (3): Rio de Janeiro, Jul-Sept. https://doi.org/10.5935/1414-8145.20140073
Bammann, R. H. et al., (2010). Alta prevalência de tuberculose resistente a medicamentos e outras micobactérias em pacientes infectados pelo HIV no Brasil: uma revisão sistemática, Mem. Inst. Oswaldo Cruz, 105 (6): Rio de Janeiro, set.
Bartholomay, P., Pinheiro, R. S., Dockhorn, F. et al. (2021). Brazilian cohort study of risk factors associated with unsuccessful outcomes of drug resistant tuberculosis. BMC Infect Dis 21, 1049. https://doi.org/10.1186/s12879-021-06756-7
Bhering, M., Duarte, R., & Kritski, A. (2021). Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 25(4), 292–298. https://doi.org/10.5588/ijtld.20.0887
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Manual de Recomendações para o Controle da Tuberculose no Brasil / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. – Brasília: Ministério da Saúde, 2019.
BVS - Biblioteca Virtual de Saúde. <http://bvsalud.org/>.
Câmara, J. T. et al., (2016). Perfil epidemiológico de pacientes com diagnóstico de resistência de Mycobacterium tuberculosis, Rev. Enferm., 10(11): UFPE, Recife-4082-9, nov. https://doi.org/10.5205/1981-8963-v10i11a11494p4082-4089-2016
Chang, J.T., Kuroki, M. L. F., Fajardo, H. F., Ortega, R. Z. (2014). Factores de riesgo en la aparición de multidrogo resistencia en pacientes con tuberculosis pulmonar. Rev méd panacea. 4(2): 31-35. https://doi.org/10.35563/rmp.v4i2.167
Chaves-Torres N. M., Fadul, S., Patiño, J., Netto, E. (2021). Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013–2015: A retrospective cohort study. PLoS ONE. 16(4): e0249565. https://doi.org/10.1371/journal.pone.0249565
Conde, M. B. et al., (2009). III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia. Jornal Brasileiro de Pneumologia [online], v. 35, n. 10. https://doi.org/10.1590/S1806-37132009001000011
Cooper, H. M. (1982). Scientific guidelines for conducting integrative research reviews. Review of Educational Research, 52(2), 291-302.
Dalcolmo, M. P. (2012). Tratamento da Tuberculose Sensível e Resistente, Pulmão ,21(1):Rio de Janeiro,55-59.
Ferreira, K. R. (2011). Portadores de tuberculose multirresistente em um centro de referência: perfil sócio-demográfico e clínico-epidemiológico. Rev. esc. enferm. USP ,45 (2): São Paulo, Dec.
Fregona, G. (2017). Fatores de risco associados à tuberculose multirresistente no Espírito Santo, Brasil. Rev. Saúde Pública, 51(27): https://doi.org/10.1590/S1518-8787.2017051006688
Gkaravela, L. et al., (2017). Combinação de ensaios moleculares disponíveis no mercado e métodos baseados em cultura no diagnóstico de tuberculose e tuberculose resistente a medicamentos. Braz. J. Microbiol., 48 (4): São Paulo out./ dez.
Global tuberculosis report 2021. World Health Organization, 2021. Licence: CC BY-NC-SA 3.0 IGO
Htun, Y.M., Khaing, T.M.M., Aung, N.M., Yin, Y., Myint, Z., Aung, S.T., et al. (2018) Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study. PLoS ONE.13(12): e0209932. https://doi.org/10.1371/journal.pone.0209932
Jaber, A.A.S., Ibrahim, B. (2019). Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance. BMC Infect Dis 19, 464. https://doi.org/10.1186/s12879-019-4069-1
Joanna Briggs Institute. System for the unified management, assessment an review of information version 4.0. South Austrália: The University of Adelaide, 2007.
Khan, F. U., Rehman, A., Khan, F.U., Hayat, K., Khan, A., Ahmad, N., Chang, J., Malik, U. R, Fang, Y. (2022). Avaliação de Fatores Associados a Resultados Desfavoráveis entre Pacientes com TB Resistentes a Medicamentos: Um Estudo Retrospectivo de 6 Anos do Paquistão. Int. J. Ambiente. Res. Saúde Pública, 19, 1574.
Kuaban, A., Balkissou, A. D., Ekongolo, M., Nsounfon, A. W., Pefura-Yone, E. W., & Kuaban, C. (2021). Incidence and factors associated with unfavourable treatment outcome among patients with rifampicin-resistant pulmonary tuberculosis in Yaoundé, Cameroon. The Pan African medical journal, 38, 229. https://doi.org/10.11604/pamj.2021.38.229.28317
Lima, G. R. C. C. (2015). Evaluation of resistance to first-line tuberculostatic drugs in isolates of Mycobacterium tuberculosis Complex in Federal District. Tese (Doutorado em Ciências Farmacêuticas) – Faculdade de Ciências da Saúde, Universidade de Brasília, Brasília.
Marques, M., et al., (2017). Resistência às drogas antituberculose na fronteira do Brasil com o Paraguai e a Bolívia. Rev Panam Salud Publica., 41: e9, fev.
Matambo, R., Nyandoro, G., Sandy, C., Nkomo, T., Mutero-Munyati, S., Mharakurwa, S., Chikaka, E., Ngwenya, M., Ndongwe, G., & Pepukai, V. M. (2021). Predictors of mortality and treatment success of multi-drug resistant and Rifampicin resistant tuberculosis in Zimbabwe: a retrospective cohort analysis of patients initiated on treatment during 2010 to 2015. The Pan African medical journal, 39, 128. https://doi.org/10.11604/pamj.2021.39.128.27726
Mendes, K. D. S., Silveira, R. C. C. P. & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto - Enfermagem, 17(4), 758-64.
Mendes, M. R. R. S., et al., (2014). Situação sóciodemográfica da tuberculose multirresistente no estado do Piauí, 2001 – 2012. R. Interd., 7(1), 8-16.
Mendes, N. M. J. A .et al., (2014). Perfil de resistência a fármacos antituberculose em um hospital de referência do Estado de Minas Gerais. Rev Med., 24 (Supl 5): S43-S46, Minas Gerais.
Moura, M. R. L., Reyes, F. G. (2002). Interação fármaco-nutriente: uma revisão. Revista de Nutrição. 15(2).
Mulu, W. et al., (2015). Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci, 15(2), 368-77, http://www.ncbi.nlm.nih.gov/pubmed/26124781
Nair, D., Velayutham B., Kannan T., Tripathy J.P., Harries A.D., Natrajan M., et al. (2017) Preditores de resultado de tratamento desfavorável em pacientes com tuberculose multirresistente na Índia. Ação de Saúde Pública., 7(1):32-38
Namburete, E. I. et al., (2016). Caracterização do perfil de resistência do Mycobacterium tuberculosis isolado de pacientes da cidade de Beira, So fala – Moçambique, Medicina (Ribeirão Preto) ,49 (4): 338-343.
Nogueira, A. F. et al., (2012). Tuberculose: uma abordagem geral dos principais aspectos, Rev. Bras. Farm. 93(1): 3-9.
Page, M.J., Moher. D., Bossuyt, P.M, et al., (2021). PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021,372:n160.
Queiroz, E. M. & Bertolozzi, M. R. (2010). Tuberculosis: supervised treatment in North, West and East Health Departments of São Paulo. Rev. Esc Enfer. USP, 44(2):449-45.
Rayyan – Intelligent Systematic Review. <https://rayyan.ai/reviews/411780>.
Ruzangi, J., Iwagami, M., Smeeth, L. et al., (2020). The association between chronic kidney disease and tuberculosis, a comparative cohort study in England. BMC Nephrol 21, 420. https://doi.org/10.1186/s12882-020-02065-4
Safaev, K., Parpieva, N., Liverko, I., Yuldashev, S., Dumchev, K., Gadoev, J., Korotych, O., Harries, A. D. (2021). Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018. International Journal of Environmental Research and Public Health. 18(9):4663.
Santos, C. M.C., Pimenta, C. A. M., Nobre, M. R. C. (2007). A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Revista Latino-Americana de Enfermagem, v. 15, n. 3, p. 508-511.
Sharma, N., Khanna, A., Chandra, S., Basu, S., Chopra, K. K., Singla, N., Babbar, N., Kohli, C. (2020). Trends and outcomes of treatment of multidrug-resistant tuberculosis in Delhi, India (2009-2014). Indian Journal of Medical Research. V 151 - Edição 6 - p 598-603.
Siqueira, H. R, et al., (2009). Resistência do Mycobacterium tuberculosis à isoniazida por mutações em duas regiões diferentes do gene katG, J Bras Pneumol.,35(8):773-779.
Soeroto, A.Y., Pratiwi, C., Santoso, P., Lestari, B. W. (2021). Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study. PLoS ONE. 16(2): e0246284. https://doi.org/10.1371/journal.pone.0246284
Tembo, B. P. M. (2019) Prevalência e fatores associados à tuberculose resistente a múltiplas drogas / rifampicina em pacientes suspeitos de tuberculose resistente a drogas no Botsuana, BMC Infectious Diseases ., 19: 779.
Ursi, E.S. (2005) Prevenção de lesões de pele no perioperatório: revisão integrativa da literatura. [dissertação]. Ribeirão Preto: Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto.
Van, L.H., Phu, P.T., Vinh, D.N., et al., (2020). Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study. BMC Infect Dis 20, 164. https://doi.org/10.1186/s12879-020-4887-1
Vries, G. et al., (2017). Fatores do sistema de saúde que influenciam o manejo da tuberculose multirresistente em quatro países da União Europeia - aprendendo com as experiências dos países. BMC Public Health 17: 334.
Wang et al. (2009). Impact of type 2 diabetes on manifestation and treatment outcome of pulmonary tuberculosis. Epidemiol Infect.137:203–10.
Wrohan, I., Nguyen, T.A., Nguyen, V.N. et al., (2022). Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study. BMC Infect Dis 22, 68. https://doi.org/10.1186/s12879-021-06992-x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Laís Ferreira Alves; Elison Costa Holanda; Leticia Thamanda Vieira de Sousa ; Giovanna Fernandes Lago Santos; Sâmia Moreira de Andrade; Evaldo Hipólito de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
